Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 7 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention
TAVR is Ready for Most Low-risk Patients
Author(s): Ahmad Jabri , Anas Alameh , Gennaro Giustino , et al Added: 9 months ago

Intervention

Vascular Disease and Surgery
Kendra J Grubb
Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more
Quality of Life After AVR
Author(s): Meng He , Jinwei Zhang , Jianbo Yu , et al Added: 1 month ago

Heart Failure
View from the Thoraxcenter: What's Hot at ACC.24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Cardiovascular Renal Metabolic
Thomas Modine
Research Area(s) / Expertise:

Stroke

 Job title: Cardiovascular and Thoracic Surgeon
Prof Thomas Modine is professor of cardiovascular surgery at Bordeaux University Hospital, Bordeaux, FR. He is a renowned surgeon in transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), minimally invasive surgery and valve sparing techniques. He is also leading basic science research programmes and is developing a percutaneous mitral programme with IP. He… View more
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 4 weeks ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 1 year ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more

Intervention
Elvin Kedhi
Job title: Interventional Cardiologist
Dr Elvin Kedhi is anInterventional Cardiologist atAZ Sint Jan, Bruges, BE. Hegraduated from the University of Padua in Italy. He specialises in interventional cardiology, transcatheter aortic valve replacement, mitral valve percutaneous intervention and left atrial appendix occluder devices. View more